Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Dec;78(3):449–453.

Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.

P Appleby 1, D G Webber 1, J G Bowen 1
PMCID: PMC1534813  PMID: 2612055

Abstract

The effect of a number of drugs commonly used to treat the more severe exacerbations of the autoimmune disease systemic lupus erythematosus (SLE) in humans has been investigated in the murine chronic graft-versus-host (GVH) induced model of lupus. This was undertaken in order to determine the value of this model for the investigation of immunomodulant drugs, with particular regard to the reproducibility of disease induction and methods of monitoring disease progression. The drugs were azathioprine, cyclophosphamide, cyclosporin A and dexamethasone. All of these, except for azathioprine, reduced disease severity, assessed as the development of lupus nephritis. Anti-ssDNA autoantibodies were also reduced in titre in the dexamethasone-treated group. Overall, these findings, combined with the reproducible induction of disease seen in this model, support the use of chronic GVH disease as a model for SLE and show that the induced disease can be ameliorated by drugs effective in the treatment of SLE in humans.

Full text

PDF
450

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruijn J. A., van Elven E. H., Hogendoorn P. C., Corver W. E., Hoedemaeker P. J., Fleuren G. J. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol. 1988 Mar;130(3):639–641. [PMC free article] [PubMed] [Google Scholar]
  2. Burlingame M. B., Delafuente J. C. Treatment of systemic lupus erythematosus. Drug Intell Clin Pharm. 1988 Apr;22(4):283–289. doi: 10.1177/106002808802200401. [DOI] [PubMed] [Google Scholar]
  3. Dosch H. M., Mansour A., Cohen A., Shore A., Gelfand E. W. Inhibition of suppressor T-cell development following deoxyguanosine administration. Nature. 1980 Jun 12;285(5765):494–496. doi: 10.1038/285494a0. [DOI] [PubMed] [Google Scholar]
  4. Gleichmann E., Van Elven E. H., Van der Veen J. P. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol. 1982 Feb;12(2):152–159. doi: 10.1002/eji.1830120210. [DOI] [PubMed] [Google Scholar]
  5. Gunn H. C. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies. Clin Exp Immunol. 1986 May;64(2):225–233. [PMC free article] [PubMed] [Google Scholar]
  6. Kimura M., Ida S., Shimada K., Kanai Y. Specificity of anti-nuclear antibodies induced in F1 mice undergoing the graft-vs-host reaction: isotypes and cross-reactivities. Clin Exp Immunol. 1987 Aug;69(2):385–393. [PMC free article] [PubMed] [Google Scholar]
  7. Pollak V. E. Treatment of lupus nephritis. Adv Nephrol Necker Hosp. 1976;6:137–161. [PubMed] [Google Scholar]
  8. Popovic S., Bartlett R. R. The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery. Agents Actions. 1987 Aug;21(3-4):284–286. doi: 10.1007/BF01966492. [DOI] [PubMed] [Google Scholar]
  9. Rolink A. G., Gleichmann H., Gleichmann E. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. J Immunol. 1983 Jan;130(1):209–215. [PubMed] [Google Scholar]
  10. Rolink A. G., Radaszkiewicz T., Melchers F. The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice. J Exp Med. 1987 Jun 1;165(6):1675–1687. doi: 10.1084/jem.165.6.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
  12. Van Rappard-Van Der Veen F. M., Radaszkiewicz T., Terraneo L., Gleichmann E. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J Immunol. 1983 Jun;130(6):2693–2701. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES